[Form 4] Absci Corp Insider Trading Activity

Rhea-AI Filing Summary

Menelas N. Pangalos, a director of Absci Corp (ABSI), reported an open-market purchase of 95,785 shares of Absci common stock on 09/22/2025 at a price of $2.66 per share. After the transaction, Mr. Pangalos beneficially owned 113,960 shares. The filing states the purchase was made in accordance with the issuer's trading policies. The Form 4 was executed by Shelby Walker as attorney-in-fact on 09/22/2025.

Positive

• Director buy disclosed: Menelas N. Pangalos purchased 95,785 shares at $2.66 on 09/22/2025
• Increased insider ownership: Beneficial ownership rose to 113,960 shares
• Compliance: Transaction reported and identified as an open-market purchase made under the issuer's trading policies

Negative

• None.

Insights

Financial Analyst

TL;DR: Director purchased 95,785 ABSI shares at $2.66, a routine open-market buy under company trading policies.

The reported transaction is a straightforward open-market purchase by a company director, increasing direct beneficial ownership to 113,960 shares. The purchase price and share count are explicitly disclosed; no derivative transactions or dispositions are reported. Because the filing contains no revenue, guidance, or material corporate developments, the direct financial impact on Absci's capital structure is limited to the transfer of existing public float. This disclosure is informative for monitoring insider alignment but does not on its own provide material operational or financial change.

Corporate Governance Expert

TL;DR: Insider purchase signals compliance with trading policies and modest insider buying, not a material governance event.

The Form 4 demonstrates procedural compliance: the purchase is disclosed, executed under company trading policies, and the signature is provided via attorney-in-fact. From a governance perspective, timely and complete reporting supports transparency. The filing includes no information about hedging, pledging, or change in director status. As presented, this is a routine disclosure rather than a governance escalation or risk signal.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Pangalos Menelas N

(Last) (First) (Middle)

C/O ABSCI CORPORATION

18105 SE MILL PLAIN BOULEVARD

(Street)

VANCOUVER WA 98683

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/22/2025		P		95,785(1)	A	$2.66	113,960	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Open market purchase of shares in accordance with Issuer's trading policies.

Remarks:

	/s/ Shelby Walker, attorney-in-fact	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Absci director Menelas Pangalos report on Form 4 (ABSI)?

He reported an open-market purchase of 95,785 shares at $2.66 per share on 09/22/2025.

How many Absci shares does Menelas Pangalos own after the reported transaction?

He beneficially owned 113,960 shares following the transaction.

Was the purchase by Menelas Pangalos made under a trading plan or policy?

The filing states it was an open-market purchase made in accordance with the issuer's trading policies.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Shelby Walker as attorney-in-fact on 09/22/2025.

Did the Form 4 report any derivative transactions or dispositions by the director?

No. The filing reports only the non-derivative open-market purchase; no derivatives or dispositions are disclosed.